Medicinal Cannabis: Study Questions Mental Health Benefits

Recent research, including a review of 54 randomized controlled trials published in The Lancet Psychiatry, indicates a lack of strong evidence supporting the use of medicinal cannabinoids for mental health conditions like depression, anxiety, and PTSD. Lead study author Dr. Jack Wilson stated that these findings question the approval of medicinal cannabis for such uses, suggesting routine use might do more harm than good.

While medicinal cannabis has shown benefits for conditions such as epilepsy and certain types of pain, its efficacy for anxiety disorders, psychotic disorders, and PTSD remains unproven. The analysis found that cannabis-based treatments are rarely justified for routine use, with a 75% higher risk of adverse side effects. Experts caution that using cannabis to manage emotional distress could delay access to proven treatments, especially for individuals with a history of psychosis.

Mental health experts emphasize the importance of recognizing why individuals turn to cannabis, noting that barriers to accessing traditional mental health care may drive this trend. However, they advise users to monitor for red flags like increased dependency or mental fogginess and seek professional support if functioning declines. The study's limitations included variability in product types, doses, and real-world use conditions, which often differ from clinical trial settings.